Skip to main content

2021 PDA/FDA Joint Regulatory Conference Main banner

Tweets by 2021 PDA/FDA Joint Regulatory Conference

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Speaker

Browse by Speaker

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

C
Cai, Bing

U.S. FDA
Review-Based Live Q&A
Bing Cai
Favorite
Review-Based Panel Discussion
Bing Cai
Favorite
Campa, Cristiana

GlaxoSmithKline
Live Q&A (ST4)
Cristiana Campa
Favorite
Quality by Design: An Indispensable Approach to Accelerate BioPharmaceutical Product Development
Cristiana Campa
Favorite
Campbell, Douglas

InterPro QRA
B5: Sterile Drug Hot Topics
Douglas Campbell
Favorite
Live Q&A (B5)
Douglas Campbell
Favorite
Casey, Monica

U.S. FDA
Live Q&A (P4)
Monica Casey
Favorite
Cavazzoni, Patrizia

U.S. FDA
Live Q&A (P1-Cavazzoni)
Patrizia Cavazzoni
Favorite
Updates from CDER
Patrizia Cavazzoni
Favorite
Chen, Gang

Regeneron Pharmaceuticals, Inc.
Live Q&A (C2)
Gang Chen
Favorite
Chesney, David

DL Chesney Consulting, LLC
Inspection-Based Live Q&A
David Chesney
Favorite
Inspection-Based Panel Discussion
David Chesney
Favorite
Live Q&A (P4)
David Chesney
Favorite
Plenary 4: Current GMP Compliance Trends and Topics
David Chesney
Favorite
Christensen, Jette

Novo Nordisk A/S
Welcome and Opening Remarks from PDA Leadership and Conference Co-Chairs
Jette Christensen
Favorite
Collins, Alicia

Bristol Myers Squibb
Capacity Planning for Individualized Therapies
Alicia Collins
Favorite
Live Q&A (C1)
Alicia Collins
Favorite
Collins, Conor

GlaxoSmithKline
Live Q&A (A4)
Conor Collins
Favorite
Process Validation Lifecycle: Benefits and Learnings from Implementation
Conor Collins
Favorite
Coulon, Carl-Helmut

INVITE GmbH
Facilitating Deployment of Autonomous Mobile Robotics (AMRs)
Carl-Helmut Coulon
Favorite
Live Q&A (C3)
Carl-Helmut Coulon
Favorite
Cowley, Darrin

AstraZeneca
Live Q&A (P1-Cowley)
Darrin Cowley
Favorite
Operating during a Global Pandemic Lessons Learned: Development through Production
Darrin Cowley
Favorite
Cruse, Alonza

U.S. FDA
Live Q&A (P3)
Alonza Cruse
Favorite
ORA Compliance Updates
Alonza Cruse
Favorite